Cross‐matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting

Allogeneic mesenchymal stromal cells (MSCs) have been used clinically for decades, without cross‐matching, on the assumption that they are immune‐privileged. In the equine model, we demonstrate innate and adaptive immune responses after repeated intra‐articular injection with major histocompatibilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowland, Aileen L., Miller, Donald, Berglund, Alix, Schnabel, Lauren V., Levine, Gwendolyn J., Antczak, Douglas F., Watts, Ashlee E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Enabling Technologies for Cell‐based Clinical Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046071/
https://www.ncbi.nlm.nih.gov/pubmed/33369287
http://dx.doi.org/10.1002/sctm.20-0435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046071/
https://www.ncbi.nlm.nih.gov/pubmed/33369287
http://dx.doi.org/10.1002/sctm.20-0435

Ejemplares similares